FIELD: medicine. SUBSTANCE: the agent comprises riboflavin, ascorbic acid, boric acid, dry polyglucin, nipagin, trilone B an freshly boiled water. The sterile solution of the ophthalmologic agent is subjected to lyophilization. EFFECT: improved properties of the agent. 4 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
OPHTHALMOLOGIC AGENT AND METHOD FOR ITS PRODUCTION | 1992 |
|
RU2014050C1 |
OPHTHALMIC PREPARATION AND METHOD OF ITS PREPARING | 2000 |
|
RU2197246C2 |
CROSS-LINKING OPHTHALMIC AGENT | 2009 |
|
RU2412707C1 |
OPHTHALMIC AGENT FOR TRANSEPITHELIAL ULTRAVIOLET CORNEAL COLLAGEN CROSSLINKING | 2014 |
|
RU2560669C1 |
OPHTHALMIC CROSS-LINKING AGENT-2 | 2012 |
|
RU2475248C1 |
METHOD OF COLLAGEN PREPARING | 1993 |
|
RU2076718C1 |
OPHTHALMOLOGICAL MEANS FOR ULTRAVIOLET CORNEAL CROSSLINKING | 2016 |
|
RU2646452C1 |
HYPOSMOTIC OPHTHALMIC MEANS FOR ULTRAVIOLET CROSSLINKING OF THIN CORNEAS | 2016 |
|
RU2631604C1 |
EYE DROPS BASED ON PHARMACEUTICALLY TOLERABLE ADDITIVE SALTS OF ACID AND METHYL ETHYL ENCEPHABOL CONTAINING COMPOSITION OF VITAMINS B | 2013 |
|
RU2528912C1 |
REPARATIVE OPHTHALMIC MEDICINAL COMPOSITION | 2009 |
|
RU2402315C2 |
Authors
Dates
1994-02-15—Published
1992-10-01—Filed